Genius Sports heads into the post-earnings week with the Street uniformly bullish on direction but quietly capitulating on price — a gap between conviction and valuation that defines the stock's current tension.
Analysts cut targets across the board in response to Q1 results reported on May 7. The pattern is consistent: every firm maintained its rating, every firm lowered its number. Citigroup trimmed to $8 from $9, BTIG moved to $9 from $10, and Needham cut hardest, dropping to $10 from $14. The mean target now rests at $10.38 — more than double the current price of $4.40. That gap is notable: even after successive rounds of target reductions, the Street is pricing in a return to $10 that the stock has not traded near in months. Investors should weigh that consensus against the persistent direction of travel on those targets, which has been uniformly downward since at least the start of 2026.
The fundamental debate is not about the direction of the business, but its pace. The bull case centres on Genius's Betting Technology division — up 31% year-on-year — and the 96% surge in Media Technology revenues driven by programmatic advertising. The bear case points to the Sports Technology and Services segment declining 15% and set for dissolution in 2026, EBITDA of $48.3 million missing expectations, and overall revenue growth of just 6%. The stock is cheap on an EV/EBITDA basis at 3.8x, and the PE ratio has ticked up to 9.7x over the past month — not a demanding multiple for a company with this kind of revenue growth in its two core divisions. EPS momentum is a genuine bright spot, ranking in the 81st percentile on a 30-day view and the 83rd on a 90-day view, suggesting that estimate revisions have been running ahead of the headline disappointment.
Short interest tells a more relaxed story than the analyst churn might imply. At 6.4% of the free float — down 10% over the past month from a peak above 17.5 million shares in early April — shorts have been retreating, not pressing. The ORTEX short score has also eased, dropping from 53.4 on April 24 to 46.0 as of May 7, moving away from elevated territory. Borrow conditions are equally loose: cost to borrow is just 0.49%, and availability is ample at 558% of short interest — meaning there are roughly five and a half shares available for every one currently borrowed. There is no squeeze pressure and no evidence of aggressive new short positioning.
Options positioning is almost entirely call-dominated, with the put/call ratio at 0.067 — well above its recent average of 0.057 but still among the lowest readings in the past year. The 52-week high on that ratio is 0.205, so even Friday's elevated reading represents relatively muted demand for downside protection. Options traders are not hedging aggressively. That contrasts with the -7.9% single-day drop on May 8, which appears to be a post-earnings reaction rather than a sign of sustained positioning shifts in the options market.
Institutional ownership adds some structural support. Mark Locke, the CEO and founder, holds 7.8% of shares. BlackRock added 361,000 shares in the most recent reporting period. Senvest and Voss Capital both hold meaningful positions built through earlier buying. The ownership base reads as an investor group that bought into the growth thesis and has not yet abandoned it, even as targets have migrated lower. The CEO's small open-market sale of 7,800 shares in March, offset by an equity award of 120,000 shares, is not a material signal either way.
The next scheduled earnings event is August 6. Until then, the key variable is whether revenue growth in the Betting Technology and Media divisions can reaccelerate to offset the ongoing ST&S wind-down — and whether the Street finds a floor on price targets before the stock reclaims any of the double-digit levels it has lost over the past six months. Peer DraftKings gained nearly 11% on the week; GBT surged 59%. That GENI ended the week up just 1.1% despite a broadly constructive tape for the sector tells its own story.
See the live data behind this article on ORTEX.
Open GENI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
